Do you mean companies that provide custom pediatric formulations with flexible dosing? If so, there are two main routes:
- Extemporaneous/custom compounding (extemporaneous formulations tailored to a patient’s dose)
- Commercial GMP manufacturing of dose-flexible pediatric products (formulations designed for easy dose adjustment at scale)
Here are common players by track. Region matters, so I can tailor a short list to your country if you share your location.
1) Compounding pharmacies and networks (extemporaneous, dose-flexible)
- Wedgewood Pharmacy (USA): large pediatric compounding practice; flavors, suspensions, and dose customization for individual patients.
- PCCA (Professional Compounding Centers of America) network (USA): provides formulary resources and support for pediatric extemporaneous preparations; assists with quality compounding for clinics and pharmacies.
- Fagron (global): supplier to compounding pharmacies; offers pediatric-ready bases, flavors, and dosing tools to enable custom formulations.
2) Contract development and manufacturing organizations (CDMOs) offering pediatric formulation development and manufacturing (scale-ready, dose-flexible forms)
- Catalent: extensive pediatric formulation development services (taste masking, suspensions, dispersible formats, and other age-appropriate dosage forms; supports clinical through commercial scale).
- Almac: pediatric formulation development and GMP manufacturing capabilities (oral liquids, dispersible tablets, etc.).
- Recipharm: development and manufacturing services for pediatric dosage forms, including liquids and solids.
- Thermo Fisher Scientific – Patheon: pediatric formulation development and manufacturing offerings covering multiple dosage forms.
- Piramal Pharma Solutions: pediatric formulation development and commercial manufacturing capabilities.
- (Region-specific CDMOs may include others like Vetter for packaging, and local specialists; I can tailor a list if you specify region.)
3) Other pointers
- If your focus is strictly on commercial products with dose flexibility (not custom compounding), many major pharma players partner with CDMOs to produce pediatric-ready formulations (liquids, dispersible tablets, mini-tablets) rather than offering pure off-the-shelf pediatric lines. A CDMO approach is common for regulators who require age-appropriate formulations across pediatric subgroups.
- For parenteral or IV pediatric needs, consider manufacturers with pediatric-optimized sterile products as well (e.g., Fresenius Kabi, etc.), depending on the product type.
If you tell me:
- your region (country/markets),
- whether you want compounding services or GMP manufacturing partnerships,
- the dosage forms you’re targeting (liquids, dispersible tablets, mini-tablets, oral suspensions, etc.),
I can provide a more precise, region-focused short list and contact points.